Li-Hua Zhao

Li-Hua Zhao

Auto-generated profile, based on publicly available information

Li-Hua Zhao

Research Center for Medicinal Structural Biology, National Research Center for Translational Medicine • Shanghai, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2019 in Science
Verified
Journal Article
Closed access
PDF file
LZLi-Hua Zhao
Li-Hua Zhao
SMShanshan Ma
Shanshan Ma
ISIeva Sutkeviciute
Ieva Sutkeviciute
DSDan-Dan Shen
Dan-Dan Shen
XZX. Edward Zhou
X. Edward Zhou
YZYan Zhou
Yan Zhou
Bone-cell regulation, fleshed out: One of many medically relevant G protein–coupled receptors, parathyroid hormone receptor-1 (PTH1R) functions in the control of calcium homeostasis and bone physiology. Zhao et al. used cryo–election microscopy to observe the structure of PTH1R in a complex with a modified form of parathyroid hormone and stimulatory G protein. The structural model helps explain how parathyroid hormone interacts with its receptor and the molecular basis for receptor activation. Science , this issue p. 148

25 February 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
FZFenghui Zhao
Fenghui Zhao
QZQingtong Zhou
Qingtong Zhou
ZCZhaotong Cong
Zhaotong Cong
KHKaini Hang
Kaini Hang
XZXinyu Zou
Xinyu Zou
MWMing-Wei Wang
Ming-Wei Wang
Glucose homeostasis, regulated by glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) is critical to human health. Several multi-targeting agonists at GIPR, GLP-1R or GCGR, developed to maximize metabolic benefits with reduced side-effects, are in clinical trials to treat type 2 diabetes and obesity. To elucidate the molecular mechanisms by which tirzepatide, a GIPR/GLP-1R dual agonist, and peptide 20, a GIPR/GLP-1R/GCGR triagonist, manifest their multiplexed pharmacological actions over monoagonists such as semaglutide, we determine cryo-electron microscopy structures of tirzepatide-bound GIPR and GLP-1R as well as peptide 20-bound GIPR, GLP-1R and GCGR. The structures reveal both common and unique features for the dual and triple agonism by illustrating key interactions of clinical relevance at the near-atomic level. Retention of glucagon function is required to achieve such an advantage over GLP-1 monotherapy. Our findings provide valuable insights into the structural basis of functional versatility of tirzepatide and peptide 20.

1 February 2020 in Molecular Cell
Verified
Journal Article
Closed access
SMShanshan Ma
Shanshan Ma
QSQingya Shen
Qingya Shen
LZLi-Hua Zhao
Li-Hua Zhao
CMChunyou Mao
Chunyou Mao
XZX. Edward Zhou
X. Edward Zhou
HXH. Eric Xu
H. Eric Xu

31 July 2023 in Nature
Verified
Journal Article
Closed access
PDF file
LZLi-Hua Zhao
Li-Hua Zhao
QHQian He
Qian He
QYQingning Yuan
Qingning Yuan
YGYimin Gu
Yimin Gu
XHXinheng He
Xinheng He
HXH. Eric Xu
H. Eric Xu

13 July 2021 in eLife
Verified
Journal Article
Open access
FZFenghui Zhao
Fenghui Zhao
CZChao Zhang
Chao Zhang
QZQingtong Zhou
Qingtong Zhou
KHKaini Hang
Kaini Hang
XZXinyu Zou
Xinyu Zou
MWMing-Wei Wang
Ming-Wei Wang
Glucose-dependent insulinotropic polypeptide (GIP) is a peptide hormone that exerts crucial metabolic functions by binding and activating its cognate receptor, GIPR. As an important therapeutic target, GIPR has been subjected to intensive structural studies without success. Here, we report the cryo-EM structure of the human GIPR in complex with GIP and a Gs heterotrimer at a global resolution of 2.9 Å. GIP adopts a single straight helix with its N terminus dipped into the receptor transmembrane domain (TMD), while the C terminus is closely associated with the extracellular domain and extracellular loop 1. GIPR employs conserved residues in the lower half of the TMD pocket to recognize the common segments shared by GIP homologous peptides, while uses non-conserved residues in the upper half of the TMD pocket to interact with residues specific for GIP. These results provide a structural framework of hormone recognition and GIPR activation.

5 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
LZLi-Hua Zhao
Li-Hua Zhao
JLJingyu Lin
Jingyu Lin
SJSu-Yu Ji
Su-Yu Ji
XZX. Edward Zhou
X. Edward Zhou
CMChunyou Mao
Chunyou Mao
HXH. Eric Xu
H. Eric Xu
The ability to couple with multiple G protein subtypes, such as Gs, Gi/o, or Gq/11, by a given G protein-coupled receptor (GPCR) is critical for many physiological processes. Over the past few years, the cryo-EM structures for all 15 members of the medically important class B GPCRs, all in complex with Gs protein, have been determined. However, no structure of class B GPCRs with Gq/11 has been solved to date, limiting our understanding of the precise mechanisms of G protein coupling selectivity. Here we report the structures of corticotropin releasing factor receptor 2 (CRF2R) bound to Urocortin 1 (UCN1), coupled with different classes of heterotrimeric G proteins, G11 and Go. We compare these structures with the structure of CRF2R in complex with Gs to uncover the structural differences that determine the selective coupling of G protein subtypes by CRF2R. These results provide important insights into the structural basis for the ability of CRF2R to couple with multiple G protein subtypes.